AtriCure gets FDA OK for Synergy ablation system

12/19/2011 | Reuters

The FDA has granted AtriCure approval for its Synergy ablation device for use in treating patients with atrial fibrillation during open-heart procedures. The Synergy system is the first such device to have been cleared for atrial fibrillation therapy in the U.S.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR